Tracking Advances in Precision Medicine for Osteoarthritis
Abstract
Osteoarthritis (OA) is a prevalent degenerative joint disease that significantly affects the quality of life for millions of individuals globally. As research in this area continues to grow, conducting a bibliometric study becomes essential to analyse publication trends, identify key focus areas and assess the overall impact of research on OA. This study aimed to undertake a comprehensive bibliometric analysis of the existing literature on OA, emphasising the urgency of understanding current trends and advancements in this field. Utilising databases such as SCOPUS, the number of publications, citation metrics and collaborative networks among researchers were evaluated. Findings indicate that "osteoarthritis" is the most frequently used author keyword among the 1.911 unique keywords identified in our analysis. Notably, we observed a peak in studies related to precision medicine for OA in 2023, with a total of 127 publications projected for 2024. The International Journal of Molecular Sciences emerged as the most productive journal in this domain, publishing 17 documents specifically focused on precision medicine for OA. Furthermore, the United States was identified as the most cited country in this research area, accumulating a total of 3.953 citations. Among individual articles, The Lancet was recognised as the most cited source, with its article titled “Osteoarthritis” receiving 2.648 citations, underscoring its substantial influence on both clinical practice and further research in OA. The data also highlights that the United States leads in both single country publications (SCP) and multiple country collaborations (MCP), reflecting its extensive resources and commitment to advancing precision medicine initiatives. Given the increasing prevalence of OA and its associated healthcare burden, this bibliometric study is crucial for guiding researchers, clinicians and policymakers in developing effective interventions and improving patient outcomes. Through this analysis, we seek to promote collaboration and innovation in OA research, ultimately enhancing management strategies for this chronic condition. These collaborative efforts across various disciplines are crucial for developing effective interventions and improving outcomes for those affected by OA.
References
Qiao L, Li M, Deng F, Wen X, Wang J, Deng H, et al. Epidemiological trends of osteoarthritis at the global regional and national levels from 1990 to 2021 with a projection from 2021 to 2050. medRxiv 2024;10.1101/2024.06.30.24309697. doi:10.1101/2024.06.30.24309697.
GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023 Aug 21;5(9):e508-e522. doi: 10.1016/S2665-9913(23)00163-7.
Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020 Nov 26;29-30:100587. doi: 10.1016/j.eclinm.2020.100587.
Höld E, Chmelar S, Aubram T, Leitner G, Nehrer S, Neubauer O, et al. Nutrition and movement to improve quality of life in patients with knee osteoarthritis: the NUMOQUA study protocol for a randomised controlled trial. Trials. 2024 Apr 9;25(1):245. doi: 10.1186/s13063-024-08048-2.
Sawitzke AD. Personalized medicine for osteoarthritis: where are we now? Ther Adv Musculoskelet Dis. 2013 Apr;5(2):67-75. doi: 10.1177/1759720X12470752.
Moretti L, Bizzoca D, Geronimo A, Moretti FL, Monaco E, Solarino G, et al. Towards precision medicine for osteoarthritis: focus on the synovial fluid proteome. Int J Mol Sci. 2022 Aug 27;23(17):9731. doi: 10.3390/ijms23179731.
Pranckutė R. Web of Science (WoS) and Scopus: The Titans of Bibliographic Information in Today’s Academic World. Publications. 2021;9:12. doi: 10.3390/publications9010012.
Baas J, Schotten M, Plume A, Côté G, Karimi R. Scopus as a curated high-quality bibliometric data source for academic research in quantitative science studies. Quanti Sci Stud. 2020;1(1):377-86. doi:10.1162/qss_a_00019.
van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010 Aug;84(2):523-38. doi: 10.1007/s11192-009-0146-3.
Aria M, Cuccurullo C. bibliometrix: An R-tool for comprehensive science mapping analysis. J Informetrics. 2017;11(4):959-75. doi: 10.1016/j.joi.2017.08.007.
Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012 Apr;2(2):1143-211. doi: 10.1002/cphy.c110025.
Roos EM, Arden NK. Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol. 2016 Feb;12(2):92-101. doi: 10.1038/nrrheum.2015.135.
Mobasheri A, Batt M. An update on the pathophysiology of osteoarthritis. Ann Phys Rehabil Med. 2016 Dec;59(5-6):333-9. doi: 10.1016/j.rehab.2016.07.004.
Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019 Apr 27;393(10182):1745-59. doi: 10.1016/S0140-6736(19)30417-9.
Wei W, Ma Y, Yao X, Zhou W, Wang X, Li C, et al. Advanced hydrogels for the repair of cartilage defects and regeneration. Bioact Mater. 2020 Oct 10;6(4):998-1011. doi: 10.1016/j.bioactmat.2020.09.030.
Nijs J, George SZ, Clauw DJ, Fernández-de-Las-Peñas C, Kosek E, Ickmans K, et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021 May;3(5):e383-e392. doi: 10.1016/S2665-9913(21)00032-1.
Hewett TE, Myer GD, Ford KR, Paterno MV, Quatman CE. Mechanisms, prediction, and prevention of ACL injuries: Cut risk with three sharpened and validated tools. J Orthop Res. 2016 Nov;34(11):1843-55. doi: 10.1002/jor.23414.
Howell SM, Shelton TJ, Hull ML. Implant survival and function ten years after kinematically aligned total knee arthroplasty. J Arthroplasty. 2018 Dec;33(12):3678-84. doi: 10.1016/j.arth.2018.07.020.
Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S18-21. doi: 10.1016/j.semarthrit.2015.11.007.
Hodgkinson T, Kelly DC, Curtin CM, O'Brien FJ. Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis. Nat Rev Rheumatol. 2022 Feb;18(2):67-84. doi: 10.1038/s41584-021-00724-w.
Yang Z, Lin J, Li H, He Z, Wang K, Lei L, et al. Bibliometric and visualization analysis of macrophages associated with osteoarthritis from 1991 to 2021. Front Immunol. 2022 Oct 4;13:1013498. doi: 10.3389/fimmu.2022.1013498.
Luo ZQ, Zhou B, Xiong H. A bibliometric analysis of exosomes therapy in the treatment of osteoarthritis from 2012 to 2022. J Pain Res. 2023 Jun 26;16:2171-88. doi: 10.2147/JPR.S407050.
Shorter E, Avelar R, Zachariou M, Spyrou GM, Raina P, Smagul A, et al. Identifying novel osteoarthritis-associated genes in human cartilage using a systematic meta-analysis and a multi-source integrated network. Int J Mol Sci. 2022 Apr 15;23(8):4395. doi: 10.3390/ijms23084395.
Thottakkattumana Parameswaran V, Hild C, Eichner G, Ishaque B, Rickert M, Steinmeyer J. Interleukin-1 induces the release of lubricating phospholipids from human osteoarthritic fibroblast-like synoviocytes. Int J Mol Sci. 2022 Feb 22;23(5):2409. doi: 10.3390/ijms23052409.
Shang X, Böker KO, Taheri S, Lehmann W, Schilling AF. Extracellular vesicles allow epigenetic mechanotransduction between chondrocytes and osteoblasts. Int J Mol Sci. 2021 Dec 10;22(24):13282. doi: 10.3390/ijms222413282.
Vaishya R, Gupta BM, Mamdapur GMN, Kappi MM, Vaish A. Global research on osteoarthritis during 1994-2023: a scientometric assessment of publications and citations. Indian J Orthop. 2024 Feb 29;58(6):650-60. doi: 10.1007/s43465-024-01111-9.
Yin F, Yang Q, He Y, Peng L, Zhao Z, He C, et al. Top 100 cited articles on osteoarthritis from 1990 to 2020. Rheumatol Immunol Res. 2021 Dec 31;2(4):241-8. doi: 10.2478/rir-2021-0033.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).